Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics announced that the defendants (the Securities and Futures Commission and the Financial Services Commission) have filed an appeal against the first-instance court ruling that was in favor of Samsung Biologics regarding administrative disposition cancellations.
📊 [Key Disclosure Details & Summary Statistics]
- Title: Confirmation of Appeal Filed by Defendants Against the First-Instance Court Ruling on the Cancellation of Dispositions by the Securities and Futures Commission and Financial Services Commission
- First-Instance Court Ruling Details:
- All dispositions issued by the Securities and Futures Commission on November 19, 2018, against Samsung Biologics Co., Ltd., and the penalty of KRW 16,000,000 imposed on Kim Tae-han on November 23, 2018, are revoked.
- The penalty of KRW 8,000,000,000 (KRW 8B) imposed by the Financial Services Commission on Samsung Biologics Co., Ltd. on December 14, 2018, is revoked.
- Litigation costs shall be borne by the defendants.
- Purport of Appeal: Revoke the first-instance ruling, dismiss all claims by the plaintiffs, and assign all litigation costs to the plaintiffs.
- Reason for Appeal: To be confirmed later
- Fact Confirmation Date: August 28, 2024
- Other Key Investment Matters:
- The fact confirmation date refers to the date the company confirmed the filing of the appeal by the defendants.
- Subsequent updates regarding the case will be disclosed through re-filings in the future.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Appellate Proceedings and Subsequent Litigation Disclosures
This announcement confirms that the administrative lawsuit will proceed to the appellate court following the defendants’ appeal against the first-instance ruling. Tracking appellate court proceedings and the eventual second-instance judgment is important for understanding the timeline for resolving legal uncertainties related to the administrative actions. Relevant updates can be verified through future disclosures or periodic reports.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This material is provided strictly for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
